Article Details

With $9.5M, Intrepida Bio Launches to Target Pancreatic Cancer & More

Retrieved on: 2019-11-04 06:52:30

Tags for this article:

Click the tags to see associated articles and topics

With $9.5M, Intrepida Bio Launches to Target Pancreatic Cancer & More. View article details on hiswai:

Excerpt

<div>Dauntless Pharmaceuticals formed in 2016, and its founders said the <b>Sofinnova</b> <b>Ventures</b>-backed firm planned to take a new approach to building ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up